PURE Bioscience, Inc.
PURE
$0.08
$0.00-1.21%
OTC PK
| 01/31/2026 | 10/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -37.29% | -7.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -37.29% | -7.33% | |||
| Cost of Revenue | -20.16% | -12.84% | |||
| Gross Profit | -47.11% | -3.85% | |||
| SG&A Expenses | 14.00% | 1.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.68% | -1.18% | |||
| Operating Income | -80.21% | -12.80% | |||
| Income Before Tax | -69.18% | -39.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -69.18% | -39.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -69.18% | -39.76% | |||
| EBIT | -80.21% | -12.80% | |||
| EBITDA | -80.42% | -12.50% | |||
| EPS Basic | -70.73% | -36.67% | |||
| Normalized Basic EPS | -69.23% | -36.84% | |||
| EPS Diluted | -70.73% | -36.67% | |||
| Normalized Diluted EPS | -69.23% | -36.84% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||